Diagenode Diagnostics logo

News

Diagenode S.A. obtains the rights to the patents covering the detection of Norwalk-like Virus I and II
April 6, 2017

Effective as of January 1, 2017, Diagenode S.A. obtains the rights to the patents covering the detection of Norwalk-like Virus I and II:US patent No. 7,202,032, EP patent No. 1329522, US patent No. 7,351,819 and EP patent No. 1329523 under licensing agreement.

Upcoming events

  • RICAI
    Dec 17-Dec 18, 2018
    Paris
  • ECCMID
    Apr 13-Apr 16, 2019
    Amsterdam
 See all events

© 2017 – Diagenode Diagnostics | ISO 13485 | Site Map | Privacy policy | Contact Us | Terms and Conditions |